CN114028520A - Lung-clearing repairing pill - Google Patents
Lung-clearing repairing pill Download PDFInfo
- Publication number
- CN114028520A CN114028520A CN202110617783.8A CN202110617783A CN114028520A CN 114028520 A CN114028520 A CN 114028520A CN 202110617783 A CN202110617783 A CN 202110617783A CN 114028520 A CN114028520 A CN 114028520A
- Authority
- CN
- China
- Prior art keywords
- lung
- effects
- cancer
- blood
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006187 pill Substances 0.000 title claims abstract description 18
- 201000010099 disease Diseases 0.000 claims abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims description 35
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 21
- 208000020816 lung neoplasm Diseases 0.000 claims description 21
- 201000005202 lung cancer Diseases 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 9
- 244000131316 Panax pseudoginseng Species 0.000 claims description 8
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 6
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 6
- 241000218176 Corydalis Species 0.000 claims description 6
- 208000008128 pulmonary tuberculosis Diseases 0.000 claims description 6
- 244000307697 Agrimonia eupatoria Species 0.000 claims description 5
- 244000163122 Curcuma domestica Species 0.000 claims description 5
- 239000004863 Frankincense Substances 0.000 claims description 5
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 5
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 5
- 241000237502 Ostreidae Species 0.000 claims description 5
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 5
- 241000270666 Testudines Species 0.000 claims description 5
- 235000000125 common agrimony Nutrition 0.000 claims description 5
- 235000020636 oyster Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 241000031023 Amana edulis Species 0.000 claims description 4
- 240000005528 Arctium lappa Species 0.000 claims description 4
- 235000003130 Arctium lappa Nutrition 0.000 claims description 4
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 4
- 240000007551 Boswellia serrata Species 0.000 claims description 4
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 4
- 241000935235 Fritillaria meleagris Species 0.000 claims description 4
- 230000002685 pulmonary effect Effects 0.000 claims description 4
- 244000144725 Amygdalus communis Species 0.000 claims description 3
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 3
- 235000008078 Arctium minus Nutrition 0.000 claims description 3
- 240000000249 Morus alba Species 0.000 claims description 3
- 235000008708 Morus alba Nutrition 0.000 claims description 3
- 206010035664 Pneumonia Diseases 0.000 claims description 3
- 241000218206 Ranunculus Species 0.000 claims description 3
- 240000003152 Rhus chinensis Species 0.000 claims description 3
- 235000014220 Rhus chinensis Nutrition 0.000 claims description 3
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 3
- 206010044302 Tracheitis Diseases 0.000 claims description 3
- 241000218989 Trichosanthes Species 0.000 claims description 3
- 235000020224 almond Nutrition 0.000 claims description 3
- 206010006451 bronchitis Diseases 0.000 claims description 3
- 235000003373 curcuma longa Nutrition 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 241000972673 Phellodendron amurense Species 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 229920002261 Corn starch Polymers 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 229940126680 traditional chinese medicines Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 56
- 210000004072 lung Anatomy 0.000 abstract description 37
- 206010028980 Neoplasm Diseases 0.000 abstract description 24
- 210000004369 blood Anatomy 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 22
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 20
- 208000026435 phlegm Diseases 0.000 abstract description 20
- 201000011510 cancer Diseases 0.000 abstract description 16
- 208000019693 Lung disease Diseases 0.000 abstract description 9
- 241000894006 Bacteria Species 0.000 abstract description 7
- 210000003437 trachea Anatomy 0.000 abstract description 7
- 206010054107 Nodule Diseases 0.000 abstract description 5
- 230000001684 chronic effect Effects 0.000 abstract description 5
- 230000003902 lesion Effects 0.000 abstract description 5
- 241000700605 Viruses Species 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 201000008827 tuberculosis Diseases 0.000 abstract description 3
- 208000004434 Calcinosis Diseases 0.000 abstract description 2
- 208000017667 Chronic Disease Diseases 0.000 abstract description 2
- 206010067482 No adverse event Diseases 0.000 abstract description 2
- 238000003915 air pollution Methods 0.000 abstract description 2
- 230000002308 calcification Effects 0.000 abstract description 2
- 239000000428 dust Substances 0.000 abstract description 2
- 244000000010 microbial pathogen Species 0.000 abstract description 2
- 230000000391 smoking effect Effects 0.000 abstract description 2
- 210000002345 respiratory system Anatomy 0.000 abstract 2
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 20
- 230000002401 inhibitory effect Effects 0.000 description 16
- 230000006870 function Effects 0.000 description 14
- 208000025865 Ulcer Diseases 0.000 description 13
- 231100000397 ulcer Toxicity 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 11
- 230000004054 inflammatory process Effects 0.000 description 11
- 230000001093 anti-cancer Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 241000193830 Bacillus <bacterium> Species 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 9
- 241000191967 Staphylococcus aureus Species 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 238000011160 research Methods 0.000 description 8
- -1 bibenzyl compound Chemical class 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 241000180649 Panax notoginseng Species 0.000 description 5
- 235000003143 Panax notoginseng Nutrition 0.000 description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 4
- 206010008479 Chest Pain Diseases 0.000 description 4
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 208000014018 liver neoplasm Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 231100000167 toxic agent Toxicity 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000590002 Helicobacter pylori Species 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940037467 helicobacter pylori Drugs 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000002439 hemostatic effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- NQGCBDWQKDAGTK-RYZVSIALSA-N Agrimophol Chemical compound CC1=C(OC)C(C(=O)CCC)=C(O)C(C[C@]2(C)C(C(C(=O)[C@H](C)CC)=C(O)C(C)=C2O)=O)=C1O NQGCBDWQKDAGTK-RYZVSIALSA-N 0.000 description 2
- NQGCBDWQKDAGTK-QDXKXIGTSA-N Agrimophol Natural products O=C(CCC)c1c(OC)c(C)c(O)c(C[C@]2(C)C(=O)C(C(=O)[C@H](CC)C)=C(O)C(C)=C2O)c1O NQGCBDWQKDAGTK-QDXKXIGTSA-N 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 229910001369 Brass Inorganic materials 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 235000014375 Curcuma Nutrition 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 241001480037 Microsporum Species 0.000 description 2
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000010951 brass Substances 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 201000002528 pancreatic cancer Diseases 0.000 description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 206010060976 Bacillus infection Diseases 0.000 description 1
- 241001313855 Bletilla Species 0.000 description 1
- 241001313857 Bletilla striata Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 241000605372 Fritillaria Species 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- ZUKLFFYDSALIQW-MSUKCBDUSA-N Iridoid glycoside Chemical compound [H][C@]12CC[C@H](C(O)=O)[C@@]1([H])[C@H](OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2 ZUKLFFYDSALIQW-MSUKCBDUSA-N 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010025598 Malignant hydatidiform mole Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- 241001250596 Pleione Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 241001480050 Trichophyton violaceum Species 0.000 description 1
- 108010021119 Trichosanthin Proteins 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- IUKLSMSEHKDIIP-BZMYINFQSA-N Verticine Chemical compound C([C@@H]1[C@@H](O)C[C@H]2[C@@H]3CC[C@@H]4[C@]5(C)O)[C@@H](O)CC[C@]1(C)[C@H]2C[C@H]3[C@@H]4CN1[C@H]5CC[C@H](C)C1 IUKLSMSEHKDIIP-BZMYINFQSA-N 0.000 description 1
- IUKLSMSEHKDIIP-LGBGXBMPSA-N Verticine Natural products O[C@H]1[C@@H]2[C@@](C)([C@@H]3[C@H]([C@@H]4[C@H]([C@H]5[C@@H]([C@@](O)(C)[C@H]6N(C[C@@H](C)CC6)C5)CC4)C3)C1)CC[C@@H](O)C2 IUKLSMSEHKDIIP-LGBGXBMPSA-N 0.000 description 1
- 241000405217 Viola <butterfly> Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- FDABVSXGAMFQQH-XZWHSSHBSA-N berbamunine Chemical compound CN1CCC2=CC(OC)=C(O)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@@H]2N(C)CCC=3C=C(C(=CC=32)O)OC)=C1 FDABVSXGAMFQQH-XZWHSSHBSA-N 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000000138 effect on histamine Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 229930190029 eleutheroside Natural products 0.000 description 1
- 239000008769 eleutheroside Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 201000004637 gastric cardia carcinoma Diseases 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229930187479 gypenoside Natural products 0.000 description 1
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000001309 inhibitory effect on influenza Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000002433 mononuclear leukocyte Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical class [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- IUKLSMSEHKDIIP-UHFFFAOYSA-N petine Natural products CC1(O)C2CCC3C4CC(O)C5CC(O)CCC5(C)C4CC3C2CN2C1CCC(C)C2 IUKLSMSEHKDIIP-UHFFFAOYSA-N 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Marine Sciences & Fisheries (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Animal Husbandry (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
With the serious air pollution, dust in working environment, smoking and other reasons in recent years, people with lung diseases are increasing. Under the condition of low immunity of a human body, some pathogenic microorganisms bacteria or viruses also invade lung or trachea of the human body in a weak way to cause infection of a respiratory system, so that the phenomena of qi, blood, phlegm, fire and depression can occur, if the disease is not cured for a long time, chronic lesions such as tuberculosis, nodules, calcifications and the like can be easily generated in the lung by pathogen lingering, and serious patients can also turn into cancer. To this I developed: the lung-clearing repairing pill is specially used for treating chronic diseases of a human respiratory system, mainly removes blood stasis, eliminates phlegm, detoxifies, eliminates stagnation and attacks evil, repairs by nourishing yin, nourishing blood, moistening lung and consolidating the constitution, has the effects of attacking and supplementing and plays a role in cooperation, can effectively remove chronic lesions in the lung and has no adverse reaction, and is a very good product.
Description
The lung clearing and repairing pill is prepared by the clinical experiments of many years and is continuously searched, researched and perfected. The formula comprises the following components: 60 g of turmeric, 50 g of pseudo-ginseng, 50 g of frankincense, 50 g of rhizoma corydalis, 60 g of acanthopanax, 60 g of gynostemma pentaphylla, 70 g of turtle shell, 60 g of oyster, 50 g of ternate buttercup root, 50 g of thunberg fritillary bulb, 50 g of almond, 40 g of white mulberry root-bark, 50 g of trichosanthes root, 50 g of Chinese gall, 40 g of rhizoma bletillae, 50 g of hairyvein agrimony, 50 g of edible tulip, 40 g of nidus vespae, 50 g of burdock, 40 g of wild chrysanthemum flower, 50 g of phellodendron bark, 50 g of scutellaria baicalensis and the like.
The formula has the functions of promoting qi and activating blood circulation, softening and resolving hard mass, tonifying qi and nourishing blood, nourishing yin and moistening lung, detoxifying and reducing phlegm, astringing lung and relieving cough. According to the functions, pharyngitis, tracheitis, bronchitis, pneumonia, pulmonary nodule, pulmonary tuberculosis, early lung cancer and the like can be effectively treated. What are the most common primary symptoms of these diseases? Cough, expectoration, hemoptysis, chest distress, chest pain, dyspnea, asthma, tightness of breath, night sweat, etc. Diseases in the lung have great threat to one's body, cause physical weakness, fatigue, and even endanger life, and attention should be paid to and active treatment should be given to the diseases so that the diseases can be improved as soon as possible.
What is the pathological mechanism of these diseases? In recent years, air pollution is more serious, or dust exists in the working environment, so that some people have a habit of smoking, and the lung of a human body is delicate and dirty and is easy to be injured or ill. When the human body has low immunity due to various reasons, the human body is easy to be infected with some pathogenic bacteria or some viruses, and the like, so that diseases of the throat, the trachea or the lung are caused. The most common bacteria include pneumococcus, staphylococcus aureus, haemophilus influenzae, streptococcus pyogenes, pseudomonas aeruginosa, klebsiella pneumoniae, bacillus anthracis, acinetobacter baumannii, legionella and the like, wherein the streptococcus pneumoniae is the most common and accounts for 50-70% of lung infection. Infection of these bacteria can cause inflammation in the trachea or lung, resulting in some turbid phlegm, which stagnates in the trachea or lung, and some irritative symptoms in the trachea or lung, such as expectoration or dry cough. When the infection of the trachea or the lung has symptoms, timely detoxification and anti-inflammation treatment is needed, most patients can be cured, but some patients have partial diseases, the local diseases are not completely eradicated, and the local diseases are converted into chronic lung lesions. If the disease occurs repeatedly, pathological cells in the lung are also degenerated into cancer in the case that the therapeutic drug is difficult to control. Some lung cancers are primary and others are metastases from other parts of the body. In either case, treatment is required as early as possible to prevent the condition from becoming worse or worse over time.
The preparation method of the lung-clearing repairing pill is not complex, the medicines are prepared according to the proportion of the formula, then the medicines are pulverized into fine powder of 200 meshes by a pulverizer, then the prepared starch adhesive is added to be fully and uniformly stirred, and the uniformly stirred powder is prepared into water pills by a full-automatic pill making machine. The prepared water-bindered pills are preferably put into a dryer to be dried. When the medicine is used for treating a patient, the medicine is taken two to three times a day according to the condition of the patient, and 8 grams of the medicine is taken each time for two to three months. The disease can be consolidated for several months according to the improvement of the disease of the patient, so that the disease is sufficiently controlled and the health is gradually recovered.
How much the therapeutic effect of the lung-heat-clearing repair pill? According to the body-friendly experience of the medicine taking condition of a plurality of patients and the feedback condition and summary of the patients after taking the medicine, the total effective rate reaches one hundred percent. Can quickly relieve the symptoms of diseases, patients feel that the bodies are not tired as before taking the medicine after taking the medicine, expectoration is more rapid, and the symptoms of asthma can be effectively controlled. After taking the medicine for two months, some patients go to a hospital for instrument detection, but find the nodules on the lung, which can be smaller than that before taking the medicine, and are better than that before taking the medicine in chest pain or sleep quality. In addition, the patients with lung cancer always cough before taking the medicine, have dry mouth and thirst and want to drink water, and by taking the lung-heat clearing and repairing pill, the dry mouth and thirst can be effectively controlled, and the cough symptoms can be relieved. The lung-heat clearing and repairing pill contains the medicines for promoting blood circulation and removing blood stasis, and is contraindicated for pregnant women. All other people can take the lung-clearing repairing pill to treat and recover as long as the chronic diseases of the trachea and the lung exist.
What is the principle of composition of the formulation? Most lung diseases are not obtained by accident, the disease time is long, focus formation exists in the lung, but blood rather than qi is injured in the deep layer of the lung, or nodules or ulcers, or local calcifications, or fibrotic foci and the like, so that firstly, the medicine is led to enter the deep layer of the focus to kill bacteria or viruses in the focus, and meanwhile, the treatment medicine is used for supplementing energy substances to the ulcer of the focus, nourishing and repairing, so that new cell tissues are grown, and through the focus of the lung, treatment methods such as effective blood circulation promotion, blood stasis removal, hardness softening, stagnation elimination, lung moistening, phlegm reduction, detoxification, hemostasis, repair and the like are performed, so that the diseases are slowly recovered in the treatment process of the effective medicine.
Curcuma rhizome has effects of activating qi-flowing, promoting blood circulation, dredging channels and relieving pain. Modern pharmacological research shows that the composition contains volatile oil and phenols, wherein the volatile oil has identified 51 components, terpenoids are mainly used, curcuma copper, zingiberene and the like are mainly used, and the phenols are mainly curcumin and the like. The traditional Chinese medicine composition has the main effects of protecting liver, benefiting gallbladder, resisting bacteria, inflammation and tumor, accelerating wound healing, resisting mutation and the like, and has a good treatment effect on lung cancer. The main functions of the pseudo-ginseng are promoting blood circulation by removing blood stasis, enriching blood and stopping bleeding, resisting tumor and aging and having stronger analgesic effect. With modern pharmacological studies, notoginseng contains ginsenoside and can promote the transformation of cancer cells into non-cancer cells, so that notoginseng is effective on cancer. The anticancer effect has been applied in the clinic, and notoginseng is regarded as an anticancer saint product in Japan and is called notoginseng ginseng. The notoginseng has the function of anticancer, and has a direct reason for the excellent hematopoietic function. Olibanum has effects of promoting blood circulation, activating qi-flowing, removing blood stasis, resisting inflammation, relieving swelling, promoting granulation, and relieving pain. The frankincense can promote increase of mononuclear leukocytes, phagocytize dead blood cells and increase of cells, improve metabolism and further play a role in resisting inflammation. It has good promoting effect on blood circulation of whole body and viscera. Rhizoma corydalis has effects of relieving pain, resisting ulcer, and improving microcirculation. The corydalis tuber total alkaloid has a treatment effect on histamine ulcer, and the levo-tetrahydropalmatine in the corydalis tuber can reduce the aggregative property of red blood cells and improve the deformability of the red blood cells, so that the internal friction of blood is reduced, the viscosity of the blood is reduced, the red blood cells can smoothly pass through capillaries, and normal microcirculation is maintained. The four medicines of turmeric, pseudo-ginseng, frankincense and rhizoma corydalis are applied together, have the functions of promoting blood circulation, removing blood stasis, promoting qi circulation and relieving pain, and have certain anticancer function, so the four medicines can play good roles of dredging collaterals, repairing and relieving pain on focus parts of lung diseases. The acanthopanax is also called as a sloppy Chinese medicament with very valuable taste. Slightly bitter and slightly sweet, warm in nature, has the effects of tonifying kidney, replenishing vital essence, benefiting qi, nourishing blood, strengthening bones and muscles, promoting blood circulation, eliminating phlegm and dampness and the like, and is suitable for long-term taking, slimming and anti-aging. The systematic research on ginseng and acanthopanax which is a related plant thereof is carried out abroad, and the acanthopanax and the ginseng have similar pharmacological action and clinical curative effect. Modern scientific researches show that acanthopanax can regulate the function of the central nervous system and has a treatment effect on insomnia. Has antifatigue, antiaging, anticancer, and anticancer effects, and can reduce the toxicity of anticancer drugs. The eleutheroside contained in the product has effects of dilating blood vessel, lowering blood pressure, regulating endocrine system disorder, resisting bacteria, relieving inflammation, improving resistance to infection, resisting tubercle bacillus infection, and promoting urination. Gynostemma pentaphyllum has effects of nourishing qi and yin, clearing away heat and toxic materials, relieving cough, eliminating phlegm, removing liver heat, lowering blood pressure, relieving inflammation, and resisting cancer. It contains ginseng-like substances, gypenoside and ginsenoside, and has the functions of strengthening body and tonifying, so that it has the good effects of supplementing qi and nourishing yin, removing toxic material, reducing blood pressure and resisting cancer, etc. Can be used for treating chronic bronchial inflammation, bronchial asthma, arteriosclerosis, hepatitis, various cancers, ulcer, insomnia, headache, etc. Carapax Trionycis has effects of nourishing yin, removing toxic substances, invigorating kidney, nourishing blood, softening and resolving hard mass. Has good effects on yin deficiency and yang hyperactivity, tidal fever and night sweat, excessive internal heat and dizziness, fever yin injury, yin deficiency and wind movement, various cancers and tumors and the like. The medical research shows that the medicine can raise the immunity of human body, promote the formation of body immunoglobulin and prolong the existence time of body antibody. The composition has effects in protecting animal liver injury, relieving anemia caused by liver injury, promoting synthesis of intrahepatic protein, and increasing content of plasma protein. It has effects in inhibiting mouse transplantation tumor, and inhibiting canceration of liver cell and lung cell. Concha Ostreae has effects in nourishing yin and blood, softening and resolving hard mass, clearing away heat, eliminating phlegm, astringing, and inducing astringency. Has effects of nourishing kidney yin and promoting blood production due to rich nutrition. The taurine contained in Concha Ostreae can promote bile secretion, discharge neutral fat accumulated in liver, and improve liver detoxification. The oyster also has good effect on treating various cancers, can treat malignant lymphoma, lung cancer, liver cancer, breast cancer and the like belonging to qi depression and phlegm stagnation symptoms, and also has certain treatment effect on spontaneous perspiration, cancerous hydrothorax and the like after chemotherapy. The acanthopanax, the gynostemma pentaphylla, the turtle shell, the oyster and the pseudo-ginseng are combined together for application, so that the traditional Chinese medicine composition has a good effect of resisting lung cancer, and has good effects of nourishing yin and blood, moistening lung and consolidating the constitution and improving symptoms on the conditions of weakness, deficiency of qi and blood and low immunity caused by lung diseases and lung cancer. Radix Ranunculi Ternati is slightly warm, and has effects of removing toxic substance, relieving swelling, clearing lung-heat, eliminating phlegm, softening and resolving hard mass. Can be used for treating pulmonary tuberculosis, lung cancer, tracheitis, bronchitis, and pharyngitis. The radix ranunculi ternati has the effects of detoxifying and sterilizing, contains the ranunculide component, has the effect of inhibiting drug-resistant human mycobacterium tuberculosis, and has the effects of inhibiting staphylococcus aureus, staphylococcus albus and shigella dysenteriae and resisting cancer. Zhejiang fritillaria has the functions of clearing heat, eliminating phlegm, resolving masses and resolving carbuncles. It mainly contains verticine and tetrahydrogen. In addition, there is a very low content of alkaloids: bematrine, bevacizine and bevacizine. It has good curative effect on various malignant tumors such as lymphoma, lung cancer, thyroid cancer, breast cancer, gastric cancer, intestinal cancer, pancreatic cancer and the like, belonging to phlegm-heat syndrome, and also has good curative effect on malignant tumor pulmonary metastasis and the like. The turtle shell, the oyster, the ternate buttercup root and the thunberg fritillary bulb have good anticancer effect when being applied simultaneously, strengthen the acting forces of softening hardness and dissipating binds, clearing away heat and toxic material and reducing phlegm, and are beneficial to relieving the ecchymosis at the focus of lung diseases and treating knots. The ten medicines are simultaneously applied, and can better play roles in resisting cancers, promoting the circulation of qi, promoting blood circulation, softening hard masses, resolving masses, moistening lung, reducing phlegm and detoxifying, and through the effects, the focus can be better activated and repaired, the therapeutic medicine can be better absorbed, so that the nodules are reduced, the ulcer focus is improved, and the effect of quickly relieving pain can be achieved.
Semen Armeniacae amarum has effects of eliminating phlegm, relieving cough and asthma, moistening lung, dispersing lung qi, lowering qi, eliminating inflammation, and loosening bowel to relieve constipation. It contains amygdalin and fatty oil, and can be used for treating cough, excessive phlegm, pharyngalgia, fever, etc. caused by respiratory system diseases. Has good effects of eliminating phlegm, regulating qi-flowing, relieving cough, and resisting inflammation. It has good therapeutic effect on lung cancer, esophageal cancer, and carcinoma of gastric cardia. Cortex Mori is cool in nature, and has effects of purging lung, promoting diuresis, relieving chest stuffiness, and loosening bowel to relieve constipation. Is clinically used for treating cough, expectoration, chest distress, short breath, unsmooth defecation and other diseases caused by lung qi obstruction and lung qi depression. Has modern pharmacological research, and cortex Mori has effects of lowering blood pressure, tranquilizing, calming, relieving convulsion, relieving pain, and cooling. The decoction has effect in inhibiting Staphylococcus aureus, Bacillus typhi and Bacillus dysenteriae. It has effects in inhibiting uterine cancer and lung cancer cells, and resisting cancer virus. Radix Trichosanthis is cool in nature, and has effects of clearing heat-fire, promoting fluid production, moistening dryness, nourishing lung, astringing qi, purging liver fire, relieving restlessness, removing toxic substance, quenching thirst, expelling pus, and relieving swelling. It contains a large amount of trichosanthin, various amino acids and peptides. It is suitable for various tumors, such as choriocarcinoma, malignant hydatidiform mole, lung cancer, nasopharyngeal carcinoma, etc. The five medicines of gynostemma pentaphylla, turtle shell, oyster shell, thunberg fritillary bulb, almond, white mulberry root-bark and trichosanthes root have cool medicinal properties and rich nutrition, have good anticancer effect, and have the effects of clearing heat, reducing phlegm, detoxifying, relieving swelling, ventilating lung, depressing qi, relieving cough, tonifying deficiency, moistening lung, promoting the production of body fluid and quenching thirst, so that the five-medicine composition has a certain treatment effect on dry symptoms of lung yin deficiency such as pharyngitis, pneumonia, phthisis and lung cancer.
Galla chinensis has toxic materials removing, anticancer, astringent, hemostatic, sore healing, and repercussive effects. It contains Galla chinensis tannin, gallic acid, acid resin, etc. Galla chinensis tannin can coagulate and destroy cancer cell prototannin, has antitumor effect, and has inhibition rate of more than 90% on mouse sarcoma S-180 and human cervical cancer cell 1C-26. The acid resin has obvious astringency on ulcer of mucous membrane and skin tissue, and has hemostatic effect by accelerating blood stasis coagulation. The decoction has obvious bacteriostatic or bactericidal effect on staphylococcus aureus, diplococcus pneumoniae, streptococcus, typhoid bacillus, dysentery bacillus, diphtheria bacillus, bacillus anthracis, pseudomonas aeruginosa and the like. Therefore, the method is very suitable for the treatment application of lung diseases. Rhizoma Bletillae is slightly cold in nature, enters lung meridian, and has effects of nourishing lung, protecting mucosa, healing sore, stopping bleeding, detumescence, promoting granulation, resisting ulcer, resisting tumor, and resisting bacteria. Can be used for treating hemoptysis, hematemesis, traumatic hemorrhage, pyocutaneous disease, skin rhagadia, pulmonary tuberculosis hemoptysis, and ulcer hemorrhage. The rhizoma Bletillae contains chemical components such as bibenzyl compound, phenanthrene compound, brass, iridoid glycoside, sterol, organic acid, sugar and glycoside, and amino acid. Modern medical research shows that the bletilla has good inhibition effect on staphylococcus aureus, bacillus subtilis, candida albicans and trichophyton, and also has good inhibition effect on human mycobacterium tuberculosis. Has good therapeutic effect on hepatocarcinoma, pulmonary carcinoma, and pulmonary tuberculosis. Herba et Gemma Agrimoniae is neutral in nature, and has hemostatic, antitussive, and pesticidal effects. It contains agrimophol, agrimony lactone, luteolin, agrimony ethyl-propylene-monomer, agrimophol, tannin, sterol, saponin and volatile oil. It has the functions of inhibiting bacillus subtilis, staphylococcus aureus, colibacillus, pseudomonas aeruginosa, shigella flexneri and typhoid bacillus, and has excellent inhibiting and killing effect on human type tubercle bacillus. Therefore, the medicine is very suitable for treating lung diseases. The three medicines of the Chinese gall, the bletilla striata and the hairyvein agrimony are simultaneously applied, but have good convergence, hemostasis and cough relieving effects, and have the functions of resisting ulcer, repairing ulcer lesion tissues, recovering and healing the lesion parts of the pulmonary tuberculous ulcer, the lung cancer and the like, so the three medicines have very strong antiulcer and anticancer effects.
Pseudobulbus Cremastrae seu pleiones is cold in nature, and has effects of clearing away heat and toxic materials, eliminating phlegm, resolving hard mass, and eliminating carbuncle, swelling and furunculosis. It contains colchicine, B-photocolchicine, colchicine and other alkaloids, polysaccharide compound, etc. Modern pharmacological research finds that polysaccharide compounds contained in the edible tulip have certain effect of inhibiting proliferation of tumor cells. Therefore, the edible tulip can be used for treating the lung cancer, and the curative effect is good. Nidus Vespae is cool in nature, and has effects of dispelling pathogenic wind, removing toxic substance, killing parasite, and resisting cancer. It contains phenolic acids, diphenylalkanes, terpenoids, nitrogen-containing compounds, brass compounds, lipids, volatile oils, trace elements including calcium, magnesium and iron, and abundant proteins, is beneficial to human health, can promote regeneration of human cells, can enhance the functions of human visceral cells, and has strong effects of dispelling pathogenic wind, removing dampness, removing toxic substances, resisting inflammation, relieving pain and resisting cancer, so it is commonly used for treating bacterial and viral infectious diseases. It has good therapeutic effect on Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhi, Proteus vulgaris, Aspergillus fumigatus, Aspergillus flavus, Fusarium solani, Leuconostoc, helicobacter pylori, etc., and on lung cancer. The burdock is cold in nature and has the functions of dispelling wind and heat, ventilating the lung and promoting eruption, detoxifying and relieving sore throat. Fructus Arctii contains arctiin, whose aglycone is fructus Arctii powder, fatty oil, small amount of stearic acid and palmitic acid, and arctosterol. The fructus Arctii has different degrees of inhibitory effects on Trichophyton violaceum, Trichophyton concentricum, Trichophyton schoenleinii, Microsporum lanuginosum, Microsporum inguinarum, Epidermophyton rubrum, Nocardia stellata, etc., and also has different degrees of inhibitory effects on Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus B, Salmonella typhi, and Mycobacterium anthropomoeae. And has certain curative effect on lung cancer. The wild chrysanthemum flower is bitter in taste and cool in nature, and has obvious effects of clearing heat and detoxicating, dispelling wind and heat, removing blood stasis, improving eyesight, reducing blood pressure, preventing and treating epidemic cerebrospinal meningitis, preventing influenza, treating hypertension, hepatitis, dysentery, carbuncle furuncle and sore. Foreign studies have shown that the wild chrysanthemum extract can inhibit the growth of liver tumor cells by inhibiting the mitosis of human liver cancer cells induced by isoproterenol. The wild chrysanthemum can be used for inhibiting pancreatic cancer, nasopharyngeal carcinoma, liver cancer, lymph cancer, lung cancer and the like, and has better inhibiting effect on staphylococcus aureus, streptococcus, pseudomonas aeruginosa, diphtheria bacillus and human type mycobacterium tuberculosis. Cortex Phellodendri has effects of clearing heat, eliminating dampness, removing toxic substance, treating sore, resisting ulcer and resisting cancer. It contains berberine, magnoline, volatile oil, stigmasterol, and copper phellodendron. Has effects in resisting pathogenic microorganism and protozoa. Has antipyretic, antiinflammatory, expectorant, and antiulcer effects. Especially has obvious inhibiting and killing effect on helicobacter pylori and also on human type tubercle bacillus. The Scutellariae radix has antibacterial, antiinflammatory, heat and dampness removing, pathogenic fire purging, and toxic materials clearing away effects. It has different degrees of inhibition effects on dysentery bacillus, typhoid bacillus, flocculus epidermophyton and Viola trichophyton. And has inhibitory effect on influenza virus and hepatitis B virus. Modern medical research finds that the scutellaria baicalensis has good inhibiting and killing effects on both helicobacter pylori and human type mycobacterium tuberculosis. The six medicines of the rhizoma pleionis, the nidus vespae, the great burdock achene, the wild chrysanthemum flower, the golden cypress and the baical skullcap root are combined for application, so that the effects of clearing heat and removing toxicity, and resisting tuberculosis, ulcer and lung cancer are enhanced, and the disease can be recovered as soon as possible.
In conclusion, the lung-clearing repairing pill is completely a formula specially used for treating chronic lung diseases, the formula composition is completely based on the pathological characteristics of the lung diseases, the medicines are reasonably matched, no adverse reaction exists, the medicines play a synergistic role, the main role of eliminating evil and detoxifying is to eliminate evil and strengthen body resistance, namely eliminating evil and strengthening body resistance, the qi circulation and the blood circulation in the formula are combined together, and the hard mass softening, the stagnation dissipating, the blood nourishing, the body fluid generating, the lung moistening, the phlegm reducing, the detoxifying, the hemostasis, the pain relieving and the repairing are consistent, and the pill can completely control the disease development and gradually restore the health no matter whether nodules, tuberculosis or inflammation or early lung cancer is taken consistently.
Claims (2)
1. The invention relates to a Chinese medicinal formula, in particular to a lung-heat clearing and repairing pill, which is used for treating the following diseases: composition for treating tracheitis, bronchitis, pneumonia, pulmonary nodule, pulmonary tuberculosis, and lung cancer. The combination is as follows: 60 g of curcuma longa, 50 g of pseudo-ginseng, 50 g of frankincense, 50 g of rhizoma corydalis, 60 g of acanthopanax, 60 g of gynostemma pentaphylla, 70 g of turtle shell, 60 g of oyster, 50 g of ternate buttercup root, 50 g of thunberg fritillary bulb, 50 g of almond, 40 g of white mulberry root-bark, 50 g of trichosanthes root, 50 g of Chinese gall, 40 g of rhizoma bletillae, 50 g of hairyvein agrimony, 50 g of edible tulip, 40 g of nidus vespae, 50 g of burdock, 40 g of wild chrysanthemum flower, 50 g of phellodendron bark, 50 g of scutellaria baicalensis and the like
2. The preparation method comprises five steps
Firstly, mixing the medicines together according to a formula
Secondly, the mixed traditional Chinese medicines are pulverized into fine powder of 200 meshes by a pulverizer
Thirdly, adding a proper amount of starch paste prepared by corn starch as an adhesive, and fully and uniformly stirring
Fourthly, putting the fine powder which is evenly stirred into a full-automatic pill making machine to prepare water pills.
And fifthly, putting the prepared water-bindered pills into a dryer and drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110617783.8A CN114028520A (en) | 2021-06-02 | 2021-06-02 | Lung-clearing repairing pill |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110617783.8A CN114028520A (en) | 2021-06-02 | 2021-06-02 | Lung-clearing repairing pill |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114028520A true CN114028520A (en) | 2022-02-11 |
Family
ID=80134215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110617783.8A Pending CN114028520A (en) | 2021-06-02 | 2021-06-02 | Lung-clearing repairing pill |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114028520A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169304A (en) * | 1996-06-28 | 1998-01-07 | 柳景臻 | Pill made from eight Chinese medicinal herbs and production technology thereof |
CN1785361A (en) * | 2005-11-16 | 2006-06-14 | 李娟� | Traditional Chinese medicine for antimicrobiology. antinflammation, phlegm transformation, calm panting |
CN102961625A (en) * | 2012-11-09 | 2013-03-13 | 成都绿迪科技有限公司 | Traditional Chinese medicine composition for treating chronic pulmonary heart disease |
CN104771729A (en) * | 2015-04-03 | 2015-07-15 | 江蕾 | Traditional Chinese medicine pill assisted to treat lung cancer and preparation method thereof |
CN104971336A (en) * | 2015-07-15 | 2015-10-14 | 唐冬香 | Traditional Chinese medicine for activating blood to relieve pain |
CN105250701A (en) * | 2015-11-06 | 2016-01-20 | 吴维章 | Natural Chinese herbal medicine for treating phthisis |
CN106177689A (en) * | 2016-08-31 | 2016-12-07 | 天津中新药业研究中心 | A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof |
-
2021
- 2021-06-02 CN CN202110617783.8A patent/CN114028520A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169304A (en) * | 1996-06-28 | 1998-01-07 | 柳景臻 | Pill made from eight Chinese medicinal herbs and production technology thereof |
CN1785361A (en) * | 2005-11-16 | 2006-06-14 | 李娟� | Traditional Chinese medicine for antimicrobiology. antinflammation, phlegm transformation, calm panting |
CN102961625A (en) * | 2012-11-09 | 2013-03-13 | 成都绿迪科技有限公司 | Traditional Chinese medicine composition for treating chronic pulmonary heart disease |
CN104771729A (en) * | 2015-04-03 | 2015-07-15 | 江蕾 | Traditional Chinese medicine pill assisted to treat lung cancer and preparation method thereof |
CN104971336A (en) * | 2015-07-15 | 2015-10-14 | 唐冬香 | Traditional Chinese medicine for activating blood to relieve pain |
CN105250701A (en) * | 2015-11-06 | 2016-01-20 | 吴维章 | Natural Chinese herbal medicine for treating phthisis |
CN106177689A (en) * | 2016-08-31 | 2016-12-07 | 天津中新药业研究中心 | A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
陈沁,等: "中西医结合治疗支气管扩张咯血临床观察", 亚太传统医药, vol. 05, no. 07, pages 49 - 50 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101919976A (en) | Traditional Chinese medicine composition for treating mouth and tongue ulcer | |
CN104436131A (en) | Pharmaceutical composition used for treating swine dysentery and preparation method of pharamceutical composition | |
CN101181444B (en) | Multi-efficacy externally used drug as well as method for preparing immersion agent thereof | |
CN104208453A (en) | Traditional Chinese medicine composition for preventing grass carp hemorrhagic disease and preparation method thereof | |
CN104997860A (en) | Traditional Chinese medicine preparation for treating duodenal ulcer and preparation method thereof | |
CN114028520A (en) | Lung-clearing repairing pill | |
CN105561098A (en) | Medicine for treating erosive beriberi | |
CN111632080A (en) | Formula for treating drug eruption dermatitis, preparation method and application | |
CN112494614A (en) | Chinese medicinal formula for preventing and treating cancer by using combination of pawpaw and various medicines | |
CN105169102A (en) | Lung-clearing decoction | |
CN114404549B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof | |
CN114129692B (en) | Traditional Chinese medicine composition for treating furunculosis and preparation method and application thereof | |
CN109771480B (en) | Traditional Chinese medicine composition for treating livestock and poultry hepatotoxicity and preparation method and preparation thereof | |
CN107952057B (en) | Traditional Chinese medicine preparation for treating acne | |
CN114010742A (en) | Turtle shell detoxicating pill | |
CN105663551A (en) | Traditional Chinese medicine preparation for patient suffering from pancreatic cancer to take after operation as well as preparation method | |
CN105641422A (en) | Traditional Chinese medicine decoction for treating hyperthyroidism | |
CN105012642A (en) | Preparation method of traditional Chinese medicine composition capable of promoting blood circulation to remove blood stasis, and stopping bleeding and relieving pain | |
CN113599451A (en) | A Chinese medicinal composition containing ginsenoside and Phellinus Linteus for treating cancer, and its preparation method | |
CN104998019A (en) | Traditional Chinese medicine composition for promoting blood circulation for removing blood stasis and reliving bleeding and pain | |
CN104998189A (en) | Traditional Chinese medicine powder for treating infantile oral ulcer of wind-heat spleen type and preparation method thereof | |
CN114028517A (en) | Fukangtong pill for women | |
CN114028486A (en) | Propolis stomach invigorating pill | |
CN104083649A (en) | Traditional Chinese medicine preparation for treating shoulder periarthritis | |
CN114470122A (en) | A Chinese medicinal composition for treating syphilis, and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
DD01 | Delivery of document by public notice |
Addressee: Chen Fengyu Document name: Notification of qualified procedures |
|
DD01 | Delivery of document by public notice | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |